UK Markets open in 6 hrs 41 mins
NIKKEI 225
28,249.24 +73.37 (+0.26%) HANG SENG
20,045.77 -156.17 (-0.77%) CRUDE OIL
90.26 +1.25 (+1.40%) GOLD FUTURES
1,804.20 +13.00 (+0.73%) DOW
32,832.54 +29.04 (+0.09%) BTC-GBP
19,683.73 +336.59 (+1.74%)
Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 02:24PM EDT
| Previous close | 35.75 |
| Open | 36.12 |
| Bid | 37.20 x 900 |
| Ask | 37.28 x 1800 |
| Day's range | 36.12 - 38.70 |
| 52-week range | 20.24 - 56.80 |
| Volume | |
| Avg. volume | 647,009 |
| Market cap | 4.547B |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | 157.75 |
| EPS (TTM) | 0.24 |
| Earnings date | 02 May 2022 - 06 May 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 71.08 |
- Zacks
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of 7.69% and 15.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Denali Therapeutics Inc. (DNLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2022 Yahoo. All rights reserved.
